ND Capital

About The Fund

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002 with a focus on disruptive technologies within various disciplines. They invest in a broad range of sectors, including life sciences, nanotechnology, and therapeutic devices. Operating with a core belief that scientific fields are increasingly converging, ND Capital posits that significant breakthroughs will emerge from this interdisciplinary nexus. With a presence across the United States and Europe, they leverage their teams in Silicon Valley, Switzerland, and the Cayman Islands to assist their portfolio companies by helping to bridge the Atlantic in securing capital, talent, and business partnerships. ND Capital has approximately $820 million in assets under management (AUM), having fully invested their third fund of $335 million AUM and moving to invest through their fourth fund targeted at $350 million. Their investment strategy encompasses a variety of sectors, stages, and technologies, and they operate as a unified team to identify and evaluate investment opportunities. Furthermore, ND Capital is committed to building impactful, enduring companies by thinking like company owners and supporting portfolio companies in their growth. They value creativity, intellect, passion, respect, and perseverance. Their founder, Aymeric Sallin, initiated ND Capital based on his conviction for potential nanotechnological advancements while their senior partner, Patrick Aebischer, has contributed his experience as former President of EPFL. Eric Moessinger, a partner at ND Capital, has a focus on life sciences, while principal Kirill Kuzmichev specializes in physical science investments. Peter Liddiard serves as the Chief Operating Officer & Chief Financial Officer, and Jonathan Nicholson and Richard Coles are part of the General Partner executive team.